Flu Vaccine for Secondary Prevention of Coronary Events

MARCH 21, 2011
This video presentation discusses the results of a new study that provides further evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome.

Click here to access this third-party resource.

SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.